Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04774640 · ClinicalTrials.gov registry record
Development of a NIPTT for Detecting Copy Number Variations
A clinical trial, sponsored by Sequenom.
- Terminated
- Registry status
- 9
- Enrollment target
NCT04774640: Clinical Trial study, sponsored by Sequenom.
NCT04774640 is a clinical trial that was terminated before completion, run by Sequenom. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04774640 was terminated before completion, sponsored by Sequenom.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
To collect whole blood samples from pregnant women for the purpose of developing, optimizing and evaluating laboratory-developed noninvasive prenatal test (NIPT) for the detection of fetal chromosomal abnormalities of interest defined as microinsertions, microdeletions and other copy number variations (CNVs). The NIPT result will be compared to the test results obtained by microarray analysis of fetal cellular material obtained by amniocentesis or chorionic villus sampling.
Primary Outcome
NIPT results will be compared to test results obtain by microarray analysis of fetal cellular material obtained by amniocentesis or chorionic villus sampling
Interventions
- DEVICE MaterniT GENOME
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-05-29 |
| Est. Completion | 2018-04-30 |
Why NCT04774640 stopped before completion
NCT04774640 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MaterniT GENOME is the first listed.
NCT04774640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04774640 about?
NCT04774640 is a clinical study titled "Development of a NIPTT for Detecting Copy Number Variations". To collect whole blood samples from pregnant women for the purpose of developing, optimizing and evaluating laboratory-developed noninvasive prenatal test (NIPT) for the detection of fetal chromosomal abnormalities of interest defined as microinsertions, microdeletions and other copy number variatio...
What is the current status of trial NCT04774640?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2014-05-29. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT04774640?
The interventions under investigation include: MaterniT GENOME (DEVICE).
Who is sponsoring clinical trial NCT04774640?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI